The only statistically significant in vitro findings were an increase in CD4+ cell proliferation and increased levels of IL-6 and IL-8 in TRD patients’ stimulated cells with high ketamine concentrations compared to lower concentrations, suggesting a potential activating effect on T cells under strong exposure to the medication. The gene discussed is CXCL8; the disease is treatment resistant depression.